A study involving 52 infertile patients diagnosed with moderate or severe endometriosis showed that the intraperitoneal administration of human recombinant IFNA-2b following endometriosis surgery resulted in a recurrence of endometriosis after 21 months [56]. This evidence concerns the gene IFNA2 and endometriosis.